The increase in the prevalence, incidence, and severity of asthma over the last 20 years 1 provides strong evidence that exposures play an important role in this disease. Although common genetic variants explain only a small portion of asthma heritability, 2 epigenetic changes could potentially explain both the non-Mendelian 3 and parent-of-origin 4 patterns of inheritance that are characteristic of asthma. Additionally, epigenetic marks can be influenced by the environment 5 ; these marks have been shown to affect the expression of transcription factors that alter the maturation of T lymphocytes, [6] [7] [8] and we have demonstrated a causal relationship between DNA methylation and both T H 2 immunity and allergic airway disease in mice. 9 Recently, we have shown that DNA methylation marks in PBMCs are associated with allergic asthma 10 and account for 13.5% of the variation in serum IgE concentrations. 11 However, the airway epithelium is the primary interface with the environment, interacts with allergens 12 and other environmental stimuli, 13 and represents a potentially important mediator of allergic airway disease. Gene expression profiles of the airway epithelium in asthmatic patients have identified genes associated with exposure to endotoxin and house dust mite allergen, 14 as well as cigarette smoke, 15 asthma, 15 and T H 2-high versus T H 2-low subphenotypes of disease. 16 More recently, it has been demonstrated that gene expression in nasal epithelia is a proxy measure for gene expression of the lower airway epithelium. 17 However, to date, no study has comprehensively characterized genome-wide DNA methylation patterns and associated changes in gene expression in nasal epithelia of patients with atopic asthma.
METHODS

Study populations
Our primary study population consisted of inner-city children aged 10 to 12 years with both atopy and persistent asthma (cases, n 5 36) or without atopy or asthma (healthy control subjects, n 5 36). 10 Study subjects were recruited at 6 sites supported by the Inner City Asthma Consortium from census tracts that contain at least 20% of households at less than the US government poverty level (see Table E1 in this article's Online Repository at www. jacionline.org). We limited our study population to 36 cases and 36 control subjects with at least 80% ciliated epithelial cells visualized from slides obtained from nasal brushings and by means of expression of the FOXJ1 gene (see Table E2 in this article's Online Repository at www.jacionline.org). The validation population consisted of 30 African American subjects aged 10 to 12 years with atopic asthma by using the same definition as the derivation cohort collected by the Inner City Asthma Consortium independent of the primary study population. The original 36 control samples were used in the validation analysis and will be referred to as shared control samples. The second validation population consisted of 24 white adults (age range, 24-74 years), 12 with and 12 without asthma, all with at least 80% ciliated epithelial cells visualized from slides obtained from nasal brushings recruited at National Jewish Health. In this cohort all asthmatic patients were also atopic, as assessed based on positive skin prick test responses for multiple allergens or RAST/Phadiatop tests. Control subjects were required to have IgE measurements less than 100 but did not have additional allergy testing performed.
DNA methylation and gene expression data collection
DNA methylation was measured on Illumina's Infinium Human Methylation 450k BeadChip (Illumina, San Diego, Calif) and validated internally and externally by using pyrosequencing with custom-designed primers (see Table E3 in this article's Online Repository at www.jacionline.org). Gene expression was assessed on Agilent Human Gene Expression arrays (G3 SurePrint 8x60k; Agilent Technologies, Santa Clara, Calif). DNA methylation and gene expression array data have been deposited in the Gene Expression Omnibus (GSE65205).
Overview of statistical analyses
The goal of our analyses was to determine whether DNA methylation and gene expression changes in nasal epithelia are associated with atopic asthma. Overall study design and workflow are presented schematically in Fig E1 in this article's Online Repository at www.jacionline.org. We identified DNA methylation changes associated with asthma for both single CpG motifs (differentially methylated probes [DMPs] ) and differentially methylated regions (DMRs). Although identification of DMPs is the most commonly used method for identification of methylation changes in Illumina arrays, 18 our rationale for identification of DMRs is 3-fold: (1) identification of regions is conceptually consistent with what is known about DNA methylation patterns in the human genome 19 ; (2) it increases power to detect associations 20 ; and (3) it has been used in other diseases. 21, 22 We also performed 2 exploratory analyses: (1) to determine whether any of the DMRs or DMPs identified in nasal epithelia were associated with nasal corticosteroid use among asthmatic patients and (2) to test whether any of the 81 DMRs we previously identified as associated with asthma in PBMCs 10 are also associated with asthma in nasal epithelia.
Statistical analyses of DNA methylation data
Data from the methylation array were normalized by using the SWAN method (Illumina), 23 and the normalized M values were used in all downstream analyses, whereas b-values on the scale of 0% to 100% are used for tables and figures. Differences between cases and control subjects are reported as percentage methylation changes by using b-values. We filtered out probes on the 450k Illumina array with known single nucleotide polymorphisms in European (CEU) and African (YRI) populations within the CpG motif.
We performed the analysis to identify differential methylation in 3 steps. In brief, these are as follows: (1) infer probabilistic estimation of expression residuals factors to account for unobserved batch effects 24 ; (2) fit linear models with limma 25 ; and (3) use comb-p 26 with a window size of 300 bp to identify regions of sustained low P values or DMRs from the P values reported by using limma. DMPs were identified by calculating q values, corresponding to false discovery rate, from linear model P values by using the method of Benjamini and Hochberg. 27 After examination of quantilequantile plots, we performed global adjustment for inflation of P values using standard methodology. Details of the analyses are outlined in the diagram in Fig E2 and the Methods section in this article's Online Repository at www. jacionline.org.
Statistical analyses of gene expression data
The R package limma 25 was used to background correct, normalize (quantile), and fit linear models for expression data. P values were based on the moderated t statistic, and q values were calculated from P values by using the method of Benjamini and Hochberg. 27 
Analysis of DNA methylation and gene expression
To understand the relationship of DMRs with gene expression changes, we considered inversely correlated (canonical) versus positively correlated pairs, limiting the analysis to genes within 5 kb of a DMR. We calculated the enrichment of inversely correlated pairs in relation to all pairs by using the binomial test. To integrate the expression and methylation data, we used a method derived from comb-p, 26 except instead of testing each methylation site for its relation to asthma status, we tested methylation regions and expression probes within 5 kb.
Additional methods are available in the Methods section in this article's Online Repository.
RESULTS
There were no significant demographic differences between patients with allergic asthma (n 5 36) and control subjects (n 5 36), although collection site approached statistical significance (Table I) . Per study design, all patients with allergic asthma were atopic based on positive skin prick test responses to at least 1 indoor allergen (data not shown) and total IgE concentrations and had airflow limitation, as indicated by spirometric measurements (Table I) .
After performing global adjustment for inflation, removing probes with known European and African single nucleotide polymorphisms at the CpG motif, and adjusting for age, sex, race/ethnicity, and unknown batch effects, we identified 119 genome-wide significant DMRs associated with 118 unique genes (Fig 1, A, and Table II and see Table E4 in this article's Online Repository at www.jacionline.org) and 118 single CpG motifs (DMPs) associated with 107 unique genes (Fig 1, B, and Table II and see Table E5 in this article's Online Repository at www.jacionline.org). The median percentage methylation change between allergic asthmatic patients and control subjects was 6.8% (range, 2.6% to 28.8%) for DMRs and 13.6% (range, 5.2% to 29.5%) for DMPs. Thirty-nine genes were identified in both the DMR and DMP analysis, but a number of genes only have DMPs or DMRs because these 2 analytic approaches are complementary. Some genes/loci with a highly significant CpG (DMP) will not be represented in the DMR analysis because there are no neighboring CpGs with low P values because the Illumina array does not interrogate all CpGs; sequence data would be needed to examine this further. On the other hand, DMR analysis identifies regions of sustained low P values in multiple CpG sites at which coverage on the Illumina array is available, but not all of these loci have 1 highly significant CpG (DMP). Representative histograms of percentage methylation estimates (b-values) in patients with allergic asthma and control subjects are shown in Fig E3 in this article's Online Repository at www.jacionline.org.
Among the 186 (DMR, DMP, or both) allergic asthmaassociated differentially methylated genes in the nasal epithelia are genes with established roles in asthma and atopy: arachidonate 15-lipoxygenase (ALOX15), calpain 14 (CAPN14), histamine N-methyltransferase (HNMT), and periostin (POSTN; Fig  1, C) . Moreover, components of the extracellular matrix (COL16A1, COL5A2, COL5A3, ELN, HAS3, and MMP14) and genes related to immunity (IFNGR2, HLKA-DPA1, LAG3, NFIL3, PRF1, and TNFSF13), cell adhesion (CTNND1, EPPK1, and GJA4), epigenetic regulation (ATXN7L1, H1F0, HIST1H1D, and METTL1), airway obstruction (GABRG3), obesity (C1QTNF1 and GPC4), and autophagy (AMBRA1) are also differentially methylated in nasal epithelia of patients with atopic asthma compared with control subjects (Fig 1, C) .
None of the allergic asthma-associated DMRs/DMPs were significantly associated with nasal corticosteroid use among asthmatic patients after adjustment for multiple comparisons. Moreover, the small degree of overlap in allergic asthmaassociated epigenetic changes in PBMCs and nasal epithelia (3 of the 81 PBMC DMRs are significant in nasal epithelia at q < 0.05, see Table E6 in this article's Online Repository at (Fig 1, A) and differentially methylated single-CpG probes (DMPs; Fig 1, B) in nasal epithelia are associated with asthma after controlling for age, sex, race/ethnicity, technical variables, and batch effects. A, Manhattan plot of adjusted P values for disease status (asthma/control) from the linear model. Each dot represents a P value for a probe on the Illumina 450k array that has been adjusted by the significance of neighboring probes within 300 bases according to their correlation. Probes within statistically significant DMRs after adjustment for genome-wide comparisons are identified by darker larger symbols. B, Manhattan plot of the false discovery rate-adjusted P values (q values) for disease status (asthma/control) from the linear model. Probes with q values of less than .05 are highlighted by darker larger symbols. C, Venn diagram depicting gene-based overlap of DMRs and DMPs. Representative genes of clinical/biological relevance to asthma that are discussed in the text are highlighted.
www.jacionline.org) is not surprising given that PBMCs are a surrogate for an asthma-associated immune response, whereas nasal epithelia are directly exposed to the environment that might influence DNA marks and the course of asthma. Moreover, the nasal epithelium represents a more pure cell population than PBMCs, and some of the methylation changes present in specific mononuclear cell subsets, such as T H 2 T-cell subsets, for example, might be diluted by the presence of other cell types. The 3 DMRs that are present in both cell types might be associated with genetic variants (methylation quantitative trait loci). 28 We also performed an enrichment analysis of methylation marks within areas of open chromatin, as assessed by means of DNAse I hypersensitivity site analysis, in cell lines profiled by ENCODE. 29 This analysis identified the strongest enrichment of allergic asthma-associated DNA methylation changes in DNAse I hypersensitivity sites in epithelial cells (q < 6.57 3 10 To begin to explore the influence of environmental exposures on the nasal epithelial epigenome, we identified 48 DMRs that are significantly associated with environmental tobacco smoke (ETS) after adjusting for age, sex, race/ethnicity, unknown batch effects, and allergic asthma. Forty-eight DMRs are in 46 unique genes (see Table E7 in this article's Online Repository at www.jacionline.org), one of which (SFRP2) overlaps with the analysis of direct cigarette smoke exposure on methylation of small airway epithelia that identified 3 genes after adjustment for genome-wide comparisons. 30 Gene expression analysis of nasal epithelia identified 53 differentially expressed genes (Fig 2, A , and see Table E8 , A, in this article's Online Repository at www.jacionline.org). Among differentially expressed genes are genes associated with asthma and allergy: ALOX15, bradykinin B1 receptor (BDKRB1), cadherin 26 (CDH26), calpain 14 (CAPN14), cathepsins C and G (CTSC and CTSG), cystatin SN (CST1), gelsolin (GSN), mast cell carboxypeptidase CPA3 and tryptases (TPSAB1 and TPSD1), NADPH oxidase 1 (NOX1), neurotrophic tyrosine kinase receptor (NTRK2), plasminogen activator inhibitor 2 (SERPINB2), and von Willebrand factor (VWF). Moreover, a number of immune-related genes with high relevance to asthma (CASP4, CCK, CCL5, CCL26, CD3G, CD55, CD6, CD74, CXCR6, HLA-DMB, HLA-DOA, KLRB1, and TCRA) are also differentially expressed in samples from patients with atopic asthma compared with those from control subjects.
Given the substantial number of immune-related differentially expressed genes, we examined the function, general tissue/cell expression patterns, 31 and immune cell-specific expression patterns 32 of all 53 differentially expressed genes to discern which genes were likely contributed by immune cells in the respiratory epithelium (see Table E8 , B). This analysis revealed 11 of the 53 of the genes as highly likely to be contributed by immune cells: B cells (HLA-DMB and HLA-DOA), mast cells (CPA3, CTSG, TPSAB1, and TPSD1), natural killer cells (KLRB1), T cells (CD3G, CD6, and TCRA), and multiple immune cells (CST1). This is consistent with published findings in the lung epithelium; for example, differential expression of mast cell genes (CPA3, TPSAB1, and TPSD1) in the airway epithelium of asthmatic patients with different immune subtypes of asthma (T H 2 high and T H 2 low) is due to accumulation of intraepithelial mast cells with a unique protease phenotype in patients with T H 2-high asthma. 33 The remaining 42 genes are specifically expressed by epithelial cells, contributed both by epithelial and immune cells, or have unknown expression patterns.
The relationship between DNA methylation and gene expression revealed enrichment of hypomethylated genes associated with increased gene expression and hypermethylated genes associated with decreased gene expression (binomial P < 2.8 3 10
26 for enrichment in inverse relationships in asthma-related DMRs [Fig 2, B] and P < 7.8 3 10
210 for allergic asthma-associated DMPs [Fig 2, C] ) within 5 kb of the transcription start site. However, a number of DNA methylation changes were not associated with canonical gene expression differences (Fig 2, B and C) . Although these results are similar when we use a 2-or 3-kb distance, beyond 5 kb of the transcription start site, we begin to lose the enrichment in anticorrelated methylation-expression pairs. We did not observe an enrichment in negatively correlated methylation-expression relationships in gene promoters compared with gene bodies, as has been previously reported 34 ; however, this analysis was underpowered.
We implemented quantitative trait locus mapping to identify methylation marks that control gene expression (methyl-eQTR or quantitative trait region). We performed 2 analyses: one centered on differentially methylated genes (union of DMRs and DMPs from Fig 1; 186 unique genes) , and the other focused on 53 differentially expressed genes (Fig 2, A) . Of the 186 allergic asthmaassociated differentially methylated genes, 158 have methylation and expression data within 5 kb, and of these, 16 (10%) have significant relationships of DNA methylation and gene expression within 5 kb (see Table E9 , A, in this article's Online Repository at www.jacionline.org). Of the 53 allergic asthma-associated differentially expressed genes, 32 (60%) have significant relationships of DNA methylation and gene expression within 5kb (see Table E9 , B). We observed a strong enrichment in significant methylation-expression pairs with 5 kb of differentially expressed genes compared with all methylation-expression pairs within 5-kb distance of each other in the genome (enrichment A, Asthma-associated gene expression changes after adjusting for age, sex, and race/ethnicity. Blue dots indicate 27 genes with q values of less than .05 for the asthma versus control comparison with high functional relevance to asthma and atopy. The size of the dot is proportional to asthma versus control fold change. B and C, Expression changes in genes within 5 kb of the nearest DMR (Fig 2, B) and DMP (Fig 2, C) . In both panels the x-axis methylation difference is represented by the mean percentage methylation difference in asthmatic patients compared with control subjects. The y-axis expression difference is represented by the mean fold change in asthmatic patients compared with control subjects (on the log 2 scale). Blue symbols represent hypomethylated genes that were associated with increased gene expression, as well as some hypermethylated genes associated with decreased gene expression. Red symbols represent methylation changes that were not associated with expected gene expression differences. Upward triangles indicate DMR/DMP location upstream of the gene, circles represent DMRs in the gene body, and downward triangles refer to DMRs/DMPs downstream of the gene.
J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 5 P 5 3.2 3 10 26 ). Both analyses identified predominantly canonical inverse correlations of methylation and expression (15 of the 16 genes in the methylation-centered analysis and 32 of the 53 in the expression-centered analysis). Importantly, both analyses demonstrated that ALOX15 has significant relationship of DNA methylation and gene expression.
Upstream regulator analysis of the 47 allergic asthma2associated genes that demonstrate canonical inverse relationships between methylation and expression by using Ingenuity Pathway Analysis revealed a significant enrichment (P < 1 3 10
24
) in cytokines (IL-13, IL-4, IL-6, IFN-g, and others), as well as transcription factors (CIITA) and growth factors (TGF-b) known to regulate gene expression profiles in asthmatic patients (see Table E10 in this article's Online Repository at www.jacionline.org). Protein-protein interaction analysis of the 47 allergic asthma2associated genes with inverse relationships of methylation and expression revealed a network of proteins, with the largest hub being RIPK2 (Fig 3) . 35 RIPK2 or CARD3 is a component of signaling complexes in both the innate and adaptive immune pathways and is critical for NOD-mediated nuclear factor kB activation and cytokine production, 36 and silencing of its expression attenuates allergic airway inflammation in mice. 37 Smaller hubs in the network include other proteins important in immunity and identified in our analysis. Taken together, these analyses support biological and disease relevance of our findings.
To determine the validity of these findings, we selected 10 loci for pyrosequencing and included an independent population of children with allergic asthma from the inner city (Table I) . Ten loci were chosen to represent genes with known relevance to asthma, loci with the largest methylation changes and methylation marks that affect gene expression. Four allergic asthmaassociated DMRs or DMPs were selected based on relevance to asthma (ALOX15, HLA-DPA1, GJA4, and POSTN), 3 were selected based on the extent of methylation differences between asthmatic patients and control subjects (LDLRAD3, ATXN7L1, and METTL1), and 3 additional loci were selected based on the allergic asthma-specific methylation-expression relationships (CCL5, CTSC, and CXCR6). Nine of these 10 loci were validated internally in the original study population (P <.05, 1-tailed t test), with the CTSC locus approaching statistical significance (P 5.12, Tables III-V and see Table E11 in this article's Online Repository at www.jacionline.org) if using nominal P values, and 8 of 10 loci were validated if stringent Bonferroni correction was applied. More importantly, all 10 loci validated in an independent population of children with allergic asthma residing in the inner city compared with control subjects from the original population (shared control design; P < .05, 1-tailed t test; Table II ) and methylation levels in 2 sets of allergic asthmatic cases are comparable (see Table E11 ). Significance levels were very similar if adjustment for age, sex, and race/ethnicity was included, demonstrating the robustness of these associations with allergic asthma. We also examined expression of these 10 genes using quantitative PCR and showed that half of them have significant changes in patients with allergic asthma compared with control subjects and are also significantly inversely correlated with methylation in the original study population, as well as independent patients with allergic asthma (Tables III-V) .
To further examine the validity and generalizability of our findings, we profiled nasal epithelia from adult white subjects, 12 atopic asthmatic patients, and 12 control subjects (cohort characteristics are shown in Table E12 in this article's Online Repository at www.jacionline.org) on Illumina methylation arrays. Using the same methods applied to our primary cohort, we identified 1766 DMPs and 370 DMRs, representing 1108 unique genes, significantly associated with asthma (genomewide adjusted P < .05) after adjustment for age, sex, and batch effects. Of the 186 genes with significant methylation changes in the primary cohort of atopic asthmatic African American children from the inner city, 67 (36%) have at least 1 genome-wide significant DMP, DMR, or both in adult white asthmatic patients (see Table E13 in this article's Online Repository at www.jacionline. org). Similarly, 56 (30%) genes also overlap with genes that have IL-13-responsive CpGs in cultured nasal epithelial cells from 57 unrelated adult lung donors. 38 These results demonstrate the external validity and generalizability of some of our findings to asthma, regardless of age, race/ethnicity, specific exposures, and conditions (cultured vs fresh cells and nasal vs lung epithelia).
DISCUSSION
Our findings demonstrate that methylation marks in the nasal epithelia of children with allergic asthma are associated with changes in gene expression. Moreover, the magnitude of these allergic asthma-associated epigenetic signals is substantial when compared with other diseases. 39, 40 These findings suggest that genes that have been previously reported to be differentially expressed in the airway epithelia of patients with allergic asthma [14] [15] [16] might be regulated by epigenetic mechanisms. The effect of aeroallergens 12 and other environmental stimuli 13 on the respiratory epithelium is a key mediator of asthma. Gene expression profiles of the allergic asthmatic airway [14] [15] [16] and nasal 17 epithelia demonstrate that these cells are involved in an active biological process. Our findings demonstrate a clear relationship between DNA methylation and gene expression in the nasal epithelia of young patients with allergic asthma by using a stringent analytic pipeline to ensure that methylation changes we identified are not false-positive results because of the influence of demographic factors or technical variables. More than half of the differentially expressed genes in our analysis have significant associations with methylation marks; this includes the asthma and allergy genes ALOX15, 41 NTRK2, 46 and VWF, 47 as well as a number of immune and extracellular matrix genes. Moreover, genes that have been identified previously as differentially expressed in the respiratory epithelia but did not reach statistical significance in our expression analysis, such as POSTN, 15, 17 are also differentially methylated. Finally, genes with the largest absolute changes in methylation observed in allergic asthma (LDLRAD3, ATXN7L1, and METTL1) have not previously been implicated in allergic asthma and represent biological candidates for future investigation. There is recent evidence that expression of ALOX15 is regulated by demethylation of H3K27me3 at the ALOX15 promoter after IL-4 treatment in epithelial cells, providing support for the specific genes identified in our analysis. 48 Importantly, the magnitude of DNA methylation changes at some of the loci is large, which is consistent with that observed in other diseased tissue, 39, 40 and these loci can become important therapeutic targets in the future, given additional evidence from cohorts with larger sample sizes. DNA methylation changes have been shown to drive tumor formation and malignant progression, 49 appear to be critical to disease pathogenesis, and represent novel therapeutic targets in cancer. DNA methyltransferase inhibitors, such as 5-azacitidine and decitabine, have been approved for the treatment of myelodysplastic syndrome 50, 51 and are being tested in patients with solid tumors. 52, 53 Methylation changes in nasal epithelia of patients with allergic asthma are, on average, approximately 10 times larger than DNA methylation changes in peripheral blood that are associated with childhood allergic asthma 10 or other diseases of the airway, such as chronic obstructive pulmonary disease. 18 The strength of the DNA methylation signal in the nasal epithelia of children with asthma was detectable even in the limited sample size of the study population. Moreover, many of the methylation marks were validated in an even smaller cohort of adult white asthmatic patients, demonstrating the generalizability of our findings to asthma. Given similarities in the nasal and airway/bronchial epithelial transcriptomes, 17 it is logical to speculate that DNA methylation in nasal epithelia could be used as a biomarker of exposure or disease; however, further work in larger cohorts will be needed to explore this biomarker's potential.
The majority of allergic asthma-associated methylation marks we identified in the nasal epithelia are hypomethylated and within gene bodies. Our results are in concordance with previous reports that have shown hypomethylation of specific genes in asthmatic patients 10, [54] [55] [56] and patients with other airway diseases, such as chronic obstructive pulmonary disease. 18 Similarly, cigarette smoke exposure is more often associated with hypomethylated regions in airway epithelia, 30 and large blocks of hypomethylation have been identified in patients with cancer. 57, 58 Although early studies focused specifically on promoter methylation as a mechanism of gene regulation, 52 more recent research has demonstrated the significance of gene body methylation 59, 60 in transcriptional regulation in both malignant 34 and nonmalignant 22 diseases. Our study is the first to show an association of gene body methylation and gene expression in patients with allergic asthma.
There are several potential causes for these methylation changes. First, nasal epithelia are subject to a number of environmental exposures that are relevant to allergic asthma and are also known to shape the epigenome; these include cigarette smoke, 30, 61 air pollution, 62 and farming aerosols. 63 Although we were unable to evaluate the effect of exposures on the epigenome because of the lack of exposure assessment in our study, this is an important future direction for the field. Second, epigenetic marks can influence the severity of allergic asthma. Previous work has shown association of DNA methylation in specific gene loci (IL6 and inducible nitric oxide synthase) in the nasal epithelia 54 and buccal cells (IFNG).
64
Finally, microbial species are also known to influence the epigenome. The differential effect of rhinovirus infection in nasal epithelia from asthmatic patients (n 5 6) compared with that from nonasthmatic subjects (n 5 3) on methylation of a small noncoding RNA locus (SNORA12) has been recently demonstrated. 65 There are several limitations to our study. First, our study design precludes us from differentiating epigenetic marks associated with allergy versus those associated with asthma. However, because most children with asthma also are atopic, our findings among children with allergic asthma are generalizable to a larger population of children with asthma. Second, we were able to evaluate the effect of exposures on the epigenome in a limited fashion by using questionnaires and not exposure assessments. We did not collect longitudinal samples and were unable to examine longitudinal variation in DNA methylation caused by changes in exposure. The current study is an observational study with small sample size showing an association between methylation biomarkers and childhood persistent asthma, and further work will be required to address the stability of the biomarker over time. The relationship between the environment and epigenome, especially in relation to conditions like allergic asthma, remains a particularly important area of future research. Third, our small sample size precluded us from assessing methylation marks in relation to disease heterogeneity and asthma endotypes, and future work in larger cohorts will be required to address this question. Fourth, although all our subjects are of self-reported African American or Dominican/Haitian descent, there is substantial genetic admixture of African ancestry in these populations, 66 ,67 and we did not examine the effect of genetics on DNA methylation. 68, 69 Fifth is the inability to detect differences in methyl-versus hydroxyl-methyl cytosine, which is thought to be a mark for demethylation. 70 Finally, our association analysis is unable to distinguish between DNA methylation marks being the cause or consequence of disease. Despite these limitations, our study identified substantial and consistent DNA methylation changes in the nasal epithelia of children with allergic asthma residing in the inner city compared with nondiseased control subjects, and these methylation marks were internally and externally validated in both children and adults. These methylation changes are associated with gene expression and need to be further evaluated in larger cohorts for their potential as biomarkers and therapeutic targets. The peculiar spatial and biological relation of epigenetic changes in the nasal epithelia of asthmatic patients suggests that these cells and these mechanisms might provide insight into the cause and pathogenesis of this persistent public health concern. 1 
Key messages
d Expression of genes related to extracellular matrix, immunity, cell adhesion, epigenetic regulation, and airflow obstruction are epigenetically regulated in nasal epithelia and associated with asthma.
d The methylation changes in nasal epithelia are substantial (median, 9.5%; range, 2.6% to 29.5%) and similar in magnitude to those observed in patients with other diseases.
d More than one third of methylation changes identified by using our analysis appear to be generalizable to atopic asthma regardless of age, sex, race/ethnicity, and specific exposures.
